vitro models human paad cell lines panc 1 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
vitro models human paad cell lines panc 1
Vitro Models Human Paad Cell Lines Panc 1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 8059 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+paad+cell+lines+panc+1/PANC-1/pm41912489-289-6-30
Average 99 stars, based on 8059 article reviews
Vitro Models Human Paad Cell Lines Panc 1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 8059 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+paad+cell+lines+panc+1/PANC-1/pm41912489-289-6-30
Average 99 stars, based on 8059 article reviews
vitro models human paad cell lines panc 1 - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
other:Article Title: SMYD2 Imparts Gemcitabine Resistance to Pancreatic Adenocarcinoma Cells by Upregulating EVI2A. Article Snippet: Although gemcitabine (GEM) is the first‐line drug for advanced pancreatic adenocarcinoma (PAAD), the development of GEM resistance severely limits the effectiveness of this chemotherapy.. This study investigated the mechanisms of ecotropic viral integration site 2 A (EVI2A) for resistance to GEM and immune evasion in PAAD.. GEM resistance‐related biomark‐ ers were predicted using GEO datasets, and GEM‐resistant PAAD cells were generated. Article Title: Single‐cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism‐related mechanisms Article Snippet: The human PAAD cell lines PANC‐1 (CRL‐1469) and BxPC‐3 (CRL‐1687), as well as the Cell Culture:Article Title: The Role and Mechanism of KIAA1429-Mediated m6A Modification in Pancreatic Adenocarcinoma. Article Snippet: This study aimed to study the mechanism by which m6A methyltransferase, KIAA1429, affect pancreatic adenocarcinoma (PAAD) cell malignant behaviors in relation to N6‐methyladenosine (m6A) modification.. RT‐qPCR, Western blot, immunohistochemistry (IHC), and m6A RNA immunoprecipitation (Me‐RIP) assays were performed on PAAD tumor and adjacent non‐ tumor tissues (n = 39) to detect KIAA1429, AKT2 mRNA and protein levels, as well as overall tissue RNA m6A methylation levels.. Tumor cells were transfected with siRNA targeting KIAA1429 (si‐KIAA1429) or plasmids overexpressing AKT2 (oe‐ AKT2). |